Atypical hyperplasia: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import Tags: mobile edit mobile web edit |
||
| Line 29: | Line 29: | ||
[[Category:Endometrial Diseases]] | [[Category:Endometrial Diseases]] | ||
{{Medicine-stub}} | {{Medicine-stub}} | ||
{{No image}} | |||
Revision as of 07:28, 10 February 2025
Atypical Hyperplasia is a medical condition characterized by abnormal growth of cells in the breast or endometrium. It is considered a precancerous condition and is associated with an increased risk of developing breast cancer or endometrial cancer.
Definition
Atypical Hyperplasia refers to the presence of abnormal cells in the breast or endometrium. The term 'atypical' denotes that these cells differ from normal cells in their size, shape, or organization, while 'hyperplasia' indicates an increase in the number of cells. This condition is not cancer, but it can be a forerunner to the onset of breast cancer or endometrial cancer.
Types
There are two types of Atypical Hyperplasia: Atypical Ductal Hyperplasia (ADH) and Atypical Lobular Hyperplasia (ALH). Both types occur in the breast tissue, but they are distinguished by the location of the abnormal cells. In ADH, the abnormal cells are in the lining of a duct, while in ALH, they are in the lobules.
Risk Factors
Several risk factors are associated with Atypical Hyperplasia. These include age, family history of breast or endometrial cancer, never having been pregnant, late menopause, and hormone therapy, particularly when estrogen is given without progesterone.
Diagnosis
Atypical Hyperplasia is usually diagnosed through a biopsy, which involves removing a small sample of tissue for examination under a microscope. The biopsy can be performed using a fine needle, a core needle, or through a surgical procedure.
Treatment
The treatment for Atypical Hyperplasia depends on the individual patient's risk factors and the extent of the condition. Options may include careful monitoring, medication, or surgery.
Prognosis
While Atypical Hyperplasia increases the risk of developing breast or endometrial cancer, it does not guarantee that cancer will develop. Regular check-ups and preventive measures can help manage the risk.
